IntrinsicIntrinsic
← Scroll for more →

Recent Updates — BCPC

October 23, 2026View Source ↗

Balchem Corporation reported third-quarter 2026 financial results with net sales reaching a record $290.7 million, an 8.6% increase from the prior year period. GAAP net earnings rose 16.0% to $46.7 million, or $1.46 per diluted share, compared to $1.24 in the previous quarter. Adjusted EBITDA increased 12.4% to $80.3 million, and adjusted EPS was $1.57. The company generated $69.8 million in operating cash flow and $57.9 million in free cash flow. Balchem repurchased approximately $28 million of common stock during the quarter. Balchem Corporation manufactures ingredients for human nutrition, animal health, and specialty products.

July 31, 2026View Source ↗

Balchem Corporation reported second quarter 2026 financial results for the period ended June 30, 2026. The company achieved record quarterly net sales of $284.0 million, an 11.2% increase year-over-year, alongside GAAP net earnings of $44.6 million and adjusted EBITDA of $77.9 million. Diluted GAAP earnings per share rose to $1.39 from $1.17 in the prior year period. Balchem also amended its senior secured revolving credit facility, increasing borrowing capacity from $550 million to $650 million and extending maturity to July 24, 2031. The company repurchased $28.8 million of common stock during the quarter. Balchem Corporation operates in the specialty chemicals industry, providing ingredients for human nutrition, animal health, and industrial applications.

July 24, 2026View Source ↗

On July 24, 2026, Balchem Corporation entered into Amendment No. 1 to its Amended and Restated Credit Agreement with JPMorgan Chase Bank, N.A. and JPMorgan SE. The amendment increases the aggregate revolving commitment from $550 million to $650 million and extends the maturity date from July 27, 2027, to July 24, 2031. Key terms include enabling the Foreign Borrower to borrow funds, eliminating a 10 basis point SOFR adjustment, and reducing applicable margins for loans at Tier 3 and 4 leverage levels by 12.5 basis points. Balchem also entered into an Omnibus Reaffirmation and Amendment Agreement regarding its existing Security and Pledge Agreement. Balchem Corporation is a specialty chemical company providing ingredients and nutritional solutions.